Carl McManama Receives Prestigious Metcalf Cup and $10,000 Prize
Dr. Carl McManama, professor of general dentistry, received the Metcalf Cup and $10,000 Prize, Boston University’s highest teaching honor, during the all-university commencement ceremony yesterday at Nickerson Field. The prestigious award is testament to Dr. McManama’s exceptional teaching skills, creativity, and commitment. "This is a wonderful honor for both Carl and the School of Dental Medicine," […]
BUSDM Accredited with Flying Colors
BUSDM’s predoctoral and advanced education programs renewed their full approval with the American Dental Association’s Commission on Dental Accreditation after a rigorous site visit September 20-22. The school garnered 20 commendations for excellence across all areas of its mission (education, research, patient care, and community service). The commission had no recommendations for change. A team […]
Cigarette Smoking Nearly Doubles Risk for Root Canal Treatment
According to a new study by Boston University School of Dental Medicine (BUSDM) Professor Elizabeth Kaye Krall appearing in the April issue of the Journal of Dental Research, cigarette smoking can lead to not only tooth discoloration and gum disease, but also a common dental procedure that helps to heal a diseased tooth—the root canal. […]
Dr. Hirschberg Gives Lecture in Argentina
Dr. Carlos Hirschberg, professor and chair, Molecular and Cell Biology, last week delivered a lecture entitled, "Nucleotide sugar transporters of the Golgi apparatus: from basic science to diseases," to a crowd of 300 as a guest of the Academies of Medicine and Sciences of Argentina. The event celebrated the centenary of the birth of Luis […]
26th Annual BOV Explores Strategic Plan
Board members from around the globe joined BUSDM Dean Spencer N. Frankl, Boston University President Robert Brown, BUMC Provost Karen Antman, and BUSDM faculty and students in Hiebert Lounge September 25 for the 26th annual Board of Visitors meeting, which focused on BUSDM’s strategic plan to improve the school’s educational, research, and scholarly excellence and […]
Castle Reception Welcomes New Endodontic Residents
BUSDM welcomed new and returning residents in the postdoctoral program in endodontics at an annual reception at the Castle September 28. The event this year coincided with the Schilder Symposium on Endodontic Excellence, and speakers including Drs. Marc Balson, Craig Baumgartner, Mark Desrosiers ENDO 06, Gerald Glickman, Roger Lacoste ENDO 75, Donna Mattscheck, Terrell Pannkuk […]
Gianelly/Schilder Symposium Honors BUSDM Innovators
BUSDM faculty, students, and alumni came together at the second biennial Gianelly/Schilder Symposium on Orthodontic and Endodontic Excellence September 28-30 at the Hyatt Regency in Cambridge. The event honored the innovative work of both Dr. Anthony Gianelly, professor and chair emeritus of the Department of Orthodontics and Dentofacial Orthopedics, and the late Dr. Herbert Schilder, […]
Orthodontics Department Awarded $10,000 to Study Graft Materials
The Office of Research Administration in late September approved a research agreement with the Japanese company Shofu, Inc. awarding BUSDM $10,000 for orthodontic research entitled Effect of Alveolar Decortication on Integration of Two Augmentation Graft Materials: Norian PDC and DFDBA. "The research project is an animal (rat) study on bone graft integration under conditions of […]
Researchers Find Link Between Dental Health and Stroke Risk
In a study published in the October issue of the Journal of Periodontology, BUSDM researchers found people ages 60 and older who have periodontal disease are at an increased risk of having a stroke. "We found that patients 60 years and older who were edentulous, partially edentulous and/or had significant clinical attachment loss were more […]
Researchers Find Antidepressant May Prevent Bone Loss
The Forsyth Institute’s Drs. Battaglino and Stashenko led a team of researchers, including Dr. Dana Graves, BUSDM professor of periodontology and oral biology, who recently found the antidepressant fluoxetine (Prozac) stimulates bone formation. The findings may be important in the treatment of osteoporosis. The study, "Fluoxetine Treatment Increases Trabecular Bone Formation in Mice," will be […]